Investment Analysts


Facebook Sets IPO Range     Thu, 3 May '12 | 3:05 PM ET

Facebook is setting its IPO valuation within a range from $85-$95 billion, with CNBC's Kayla Tausche and Max Wolff, GreenCrest Capital senior analyst.

Time to Invest in Homebuilders?     Thu, 3 May '12 | 2:18 PM ET

Homebuilder losses are narrowing compared to previous quarters, so is it time to buy into the sector? Megan McGrath, MKM Partners senior analyst offers insight.

Andy Busch, BMO Capital, discusses his play on currencies ahead of tomorrow's jobs report.

CNBC's Steve Liesman offers insight on unemployment data and which economic indicator best gauges the health of the U.S. economy. Ken Sena, Evercore Partners analyst, also shares his expectations for LinkedIn ahead of its earnings report this afternoon.

Is Green Mountain Coffee Investable?     Thu, 3 May '12 | 12:19 PM ET

Oil futures are falling for the second day in a row, with the FMHR traders. Bill Chappell, SunTrust Robin Humphrey analyst, also discusses whether Green Mountain Coffee might have lost credibility for investors.

Whole Foods' Organic Growth     Thu, 3 May '12 | 9:48 AM ET

Whole Foods profit topped Wall Street's expectations, ringing up earnings of 64 cents per share. Charles Grom, senior analyst at Deutsche Bank, weighs in.

Pepsi's New Campaign: 'Live for Now'     Wed, 2 May '12 | 3:16 PM ET

Debating whether PepsiCo's new campaign and 4% dividend raise will boost investor confidence, with Jack Russo, Edward Jones senior analyst and Caroline Levy, CLSA beverage analyst.

Stocks to Watch: KFT, T & OPEN     Wed, 2 May '12 | 2:02 PM ET

CNBC's Mandy Drury speaks to Erin Lash, Morningstar; Christopher King, Stifel Nicolaus; and Jason Helfstein, Oppenheimer, regarding how to trade three stocks: Kraft, AT&T and OpenTable.

Halftime Final Trade: DB, XBI & LPX     Wed, 2 May '12 | 12:59 PM ET

The FMHR traders share their final trades of the hour.

Southwest Airlines' Primary Cost: Fuel     Wed, 2 May '12 | 12:41 PM ET

The FMHR traders discuss the state of the U.S. homebuilders industry, with Mike Murphy, Rosecliff Capital. CNBC's Kate Kelly also reports on Southwest Airlines' latest fuel strategy.

Earnings: Papa Johns, Visa & More     Wed, 2 May '12 | 12:15 PM ET

Papa Johns soars 17% post earnings, with the FMHR traders. Moshe Orenbuch, Credit Suisse analyst, also discusses whether to buy Visa ahead of its earnings report today after the closing bell.

More Downside for Chesapeake?     Wed, 2 May '12 | 12:00 PM ET

The FMHR traders discuss how the markets are faring since disappointing jobs data. Robert Morris, Citigroup analyst and Dan Dicker, MercBloc president, also discuss the drama surrounding Chesapeake Energy's CEO Aubrey McClendon and the trade on natural gas.

Sears Shareholders Sound Off!     Wed, 2 May '12 | 11:55 AM ET

Discussing whether Sears is on a "reinvention path," with Paul Swinand, Morningstar analyst, and Todd Sullivan, a Sears shareholder and a general partner at Rand Strategic Parnters.

Betting on the European Banks     Wed, 2 May '12 | 10:21 AM ET

Insight on how U.S. hedge funds have been making money on the European banks, with Chris Wheeler, bank analyst at Mediobanca.

P.F. Chang's Buyout Trade     Tue, 1 May '12 | 5:47 PM ET

The Fast Money traders answer a live viewer "tweet" on Novagold, and does PF Chang's buyout mark the beginning of a run in casual dining companies? With Nicole Miller Regan, Piper Jaffray analyst.

How to Trade Broadcom's Earnings     Tue, 1 May '12 | 5:31 PM ET

The Fast Money traders answer a live viewer "tweet" and weigh in on the play on Broadcom's numbers, with Romit Shah, Nomura Securities analyst, discussing his "buy" rating and $45 price target on Broadcom.

The Fast Money traders weigh in on the trade on CHK, and Timothy Rezvan, Sterne Agee analyst, breaks down the disappointing numbers on Chesapeake Energy, reporting Q1 EPS of $0.18 ex-items vs. FactShet $0.28. Also, CNBC's Jon Fortt reports on the after-hours action in shares of Broadcom.

Herbalife: Buying Opportunity?     Tue, 1 May '12 | 3:42 PM ET

Tim Ramey, D.A. Davidson analyst, explains why he sees a buying opportunity in Herbalife.

BlackBerry 10: RIM's LIfeline?     Tue, 1 May '12 | 2:54 PM ET

Discussing whether the development of RIM's BlackBerry 10 OS can save the company, with Mark McKechnie, Think Equity and Sameet Kanade, Northern Securities.

How to Trade Currencies     Tue, 1 May '12 | 12:51 PM ET

Todd Gordon, Aspen Trading Group discusses the current trade on the U.S. and Australian Dollar.

Investing in Latin America     Tue, 1 May '12 | 12:41 PM ET

Discussing the scope of development, growth and value in Brazil, with William Landers, BlackRock. Stacy Rasgon, Bernstein, also explains his positive expectations for Qualcomm.

Groupon Board Shake-up     Tue, 1 May '12 | 10:11 AM ET

Groupon's board is getting a major shake-up. Jordan Rohan, analyst at Stifel Nicolaus, weighs in.

Is the market getting defensive this election year? Steve Suttmeier, Bank of America technical analyst, weighs in on where investors can find growth and yield, as tech and financials switch places in the risk-reward plays.

The Trade Ahead of Pfizer's Earnings     Mon, 30 Apr '12 | 5:22 PM ET

Mark Schoenebaum, ISI Group analyst, explains why he thinks Pfizer will modestly beat expectations tomorrow and discusses several new drugs in the company's pipeline.

The Fast Money traders weigh in on whether it makes sense to trade the Barnes & Noble bump, and Colin Gillis, BGC Financial technical analyst, explains why Microsoft is his "top value pick" on the heels of the tech giant's announcement to invest $300M in Barnes & Nobel.

Spring Renewal for Gap?     Mon, 30 Apr '12 | 12:51 PM ET

Shares of Gap are up over 54% year-to-date. Discussing the latest improvements in the retailer's business strategies, with Adrienne Tennant, Janney Montgomery analyst.

Pfizer's Pipeline Plan     Mon, 30 Apr '12 | 12:45 PM ET

Catherine Arnold, senior analyst at Credit Suisse, discusses her company's "buy" rating on Pfizer ahead of the company's Q1 earnings report.

GNC Responds to DMAA Warnings     Mon, 30 Apr '12 | 12:43 PM ET

CNBC's Darren Rovell reports on how shares of GNC Holdings and Vitamin Shoppe are faring since the FDA sent warning letters regarding an ingredient in some of the companies' products.

Buy Stocks in May?     Mon, 30 Apr '12 | 12:43 PM ET

Discussing whether investors should "sell in May" or invest when the market "breaks," with Sean Clark, Clark Capital Management.

New Application for Windows 8     Mon, 30 Apr '12 | 12:00 PM ET

Shares of Barnes & Noble are soaring today on news that the bookseller has formed a partnership with Microsoft. Ed Maguire, CLSA analyst discusses.